Page last updated: 2024-10-18

dihydroxyphenylalanine and Nesidioblastosis

dihydroxyphenylalanine has been researched along with Nesidioblastosis in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Nesidioblastosis: An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and CONGENITAL HYPERINSULINISM. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Heide, LJ1
Glaudemans, AW1
Oomen, PH1
Apers, JA1
Totté, ER1
van Beek, AP1

Other Studies

1 other study available for dihydroxyphenylalanine and Nesidioblastosis

ArticleYear
Functional imaging in hyperinsulinemic hypoglycemia after gastric bypass surgery for morbid obesity.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:6

    Topics: Adult; Carbon Radioisotopes; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gastric Bypass;

2012